Valneva SE

Company Description

---

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19 and chikungunya. Valneva’s portfolio also includes two commercial vaccines for travelers.

Year founded

---

2013

Served area

---

Worldwide

Headcount

---

762

Headquarters

---

6 Rue Alain Bombard, 44800 Saint-Herblain – France